Justin Hall WESTLAKE, Ohio, April 28, 2025--(BUSINESS WIRE)--Nordson Corporation (Nasdaq: NDSN) announced today that Justin Hall has been promoted to Executive Vice President (EVP) and Medical and Fluid Solutions (MFS) segment leader. Mr. Hall joined Nordson in 2006 and has a strong performance track record. He has held leadership positions within the Company’s three segments and built deep expertise in deploying the NBS Next growth framework. Stephen Lovass, former EVP and MFS segment leader, will be leaving the Company, effective immediately. "Justin is a tenured Nordson leader who has deployed NBS Next holistically to position the Company for organic growth in multiple end markets. I am looking forward to his new perspective and partnership within MFS," said President and Chief Executive Officer Sundaram Nagarajan. Mr. Nagarajan continued, "Our medical portfolio is well positioned with differentiated products and a close-to-the-customer business model. The Atrion acquisition in 2024 further enhanced our customer offering. Medical is an attractive end market fueled by long-term growth drivers, including aging of the population, increasing healthcare spending and procedures, adopting of minimally invasive surgical techniques and continuing innovation. We must execute on the market opportunities, and I believe Justin and his medical leadership team will return this segment to above-market growth." "We appreciate Stephen’s many contributions to Nordson over the years. His leadership has positioned the MFS segment to move forward on its organic growth journey," said Mr. Nagarajan. More information about Justin Hall Justin joined Nordson's Industrial Coating Systems business in 2006 as an application engineer, and subsequently held positions of increasing responsibility, including leadership roles for Nordson Sealant Equipment and automotive businesses globally. In 2020, he was promoted to general manager, Nordson MEDICAL Fluid Components, where he led the implementation of NBS Next as one of the first divisions involved in the NBS Next pilot program. This positioned the business to meet the unprecedented customer demand for medical fluid components during the pandemic. Most recently, Justin was the vice president of the Electronics Processing Systems business where he holistically deployed NBS Next to position the business for profitable growth as the semiconductor packaging cycle begins to inflect. Mr. Hall holds a B.S. in electrical engineering from Cleveland State University and an MBA from the University of Northern Colorado. Story Continues Nordson Corporation is an innovative precision technology company that leverages a scalable growth framework to deliver top tier growth with leading margins and returns. The Company’s direct sales model and applications expertise serves global customers through a wide variety of critical applications. Its diverse end market exposure includes consumer non-durable, medical, electronics and industrial end markets. Founded in 1954 and headquartered in Westlake, Ohio, the Company has operations and support offices in over 35 countries. Visit Nordson on the web at www.nordson.com, www.twitter.com/Nordson_Corp or www.facebook.com/nordson. View source version on businesswire.com: https://www.businesswire.com/news/home/20250428677805/en/ Contacts Lara Mahoney Vice President, Corporate Communications & Investor Relations 440.204.9985 [email protected] View Comments
Nordson Corporation Announces Medical and Fluid Solutions Segment Leadership Transition
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...